期刊文献+

社区高血压患者血压控制及降血压药物使用情况 被引量:2

Analysis of Status of Controlling Blood Pressure and Anti-hypertensive Drugs Used in Community Hospital
下载PDF
导出
摘要 目的调查社区高血压患者血压控制及降压药物使用情况,为社区高血压患者的治疗提供参考。方法按照单纯随机抽样的方法,对6个社区的600名高血压患者采取问卷调查方式。结果①社区高血压患者血压控制率为54.51%,27.26%的患者有合并症或并发症;②使用的降压药物分类结果显示,钙离子拮抗剂居首位,有43.28%的患者使用,其次为复方降压药、ACEI类药物,分别有38.43%和25.18%的患者使用,其他降压药如利尿剂、β-受体阻滞剂等应用相对较少;③23.88%的患者单用一种复方降压药物,29.48%的患者单用一种降压成份药物,34.33%的患者进行非复方联合用药,而12.31%的患者进行复方制剂联合用药。结论社区血压控制率较低,所用的降压药物种类分布基本合理,但联合用药相对普遍,部分患者存在重复用药现象。建议加强社区高血压的健康教育,提高血压控制的效果。 Objective To assess the current status and trend of the use of anti-hypertensive drugs in chaoyang district guilin community health service center of changchun.Methods1000 patients with hypertension in 10 communities were selected in random and were investigated by questionnaires.ResultsThe blood pressures were controlled well in 54.04% of the patients with hypertension,and there were 27.60% of patients who had other diseases.Calcium channel blockers were used most popularly with a utilization rate of 43.22%.Compound formulation and ACEI were in the second and third places with utilization rates of 38.41% and 24.97% respectively.Other hypertensive drugs were used seldom such as diuretics and-receptor blockers.23.85% of patients took one compound formulation,29.45% of patients took one drug which contained one active compound,37.74% of patients took not less than two drugs which contained one active compound,and 14.56% of patients took not less than two compound formulations.ConclusionThe rate of controlling blood pressure is low,but the drug usage of hypertensive patients is rational basically.Combined usage of anti-hypertensive drugs is popular,but some patients repeat the usage of compound formulations.That suggests health education of hypertension be enhanced to improve the effect of controlling blood pressure.
作者 刘巍
出处 《中国医药指南》 2011年第12期31-32,共2页 Guide of China Medicine
关键词 社区医院 高血压 抗高血压药物 Community hospital Hypertension Anti-hypertensive drugs
  • 相关文献

参考文献3

二级参考文献17

  • 1王文,成云芳,刘力生.中国北京上海广州门诊高血压患者脑卒中风险评估[J].中华高血压杂志,2007,15(z1):14-20. 被引量:16
  • 2鄢琳,王振纲.探讨中国、美国及欧洲高血压防治指南中有关药物治疗的问题[J].中国药理学通报,2006,22(1):14-19. 被引量:36
  • 3Nissen SE,Murat Tuzcu,Libby P,et al.for the CAMELOT investigators.Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure[J].JAMA,2004,292:2217-2226.
  • 4The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group.Major outcomes in high-risk hypertensive patients randomized to angiotensin -converting enzyme inhibitor or calcium channel blocker vs diuretic:The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)[J].JAMA,2002,288:2981-2997.
  • 5Chobanian AV,Bakris GL,Black HR,et al.Seventh report of the joint national committee on prevention,detection,evaluation,and treatment of high blood pressure[J].Hypertension,2003,42:1206-1252.
  • 6Whitworth JA:World Health Organization,International Society of Hypertension Writing Group.2003 World Health Organization(WHO)/International Society of Hypertension(ISH) statement on management of hypertension[J].J Hypertens,2003,21(11):1983-1992.
  • 7Siegal D,Lopez J.Trends in antihypertensive drug use in the United States:do the JNC-V recommendations affect prescribing? Fifth Joint National Commission on the Detection,Evaluation,and Treatment of High Blood Pressure[J].JAMA,1997,278:1745-1748.
  • 8Staessen JA,Gasowski J,Wang JG,et al.Risks of untreated and treated isolated systolic hypertension in the elderly:meta-analysis of outcome trials[J].Lancet,2000,355:865-872.
  • 9刘力生主编.中国高血压防治指南(2005年修订版)[M].北京:人民卫生出版社,2005.20-30.
  • 10宫兆滨.β_1受体阻滞剂用于心肌梗死的二级预防临床意义[J].中国误诊学杂志,2007,7(30):7253-7254. 被引量:1

共引文献68

同被引文献9

  • 1Hedayati SS, Elsayed EF, Reilly RF. Non pharmacological as- pects ofblood pressure management:what are the data? Kid ney Int, 2011,79 : 1061-1070.
  • 2Centers for Disease Control and Prevention(CDC). CDC Grand Rounds: Dietary Sodium Reduction Time for Choice. Morb Mortal Wkly Rep 2012,61 : 89 91.
  • 3Centers for Disease Control and Prevention(CDC). Usual sodi- um intakes compared with current dietary guidelines United States, 2005 2008. Morb Mortal Wkly Rep, 2011,60 : 1413-1417.
  • 4Li Z, Heber D. Sarcopenic obesity in the elderly and strategies for weight management. Nutr Rev, 2012,70 : 57- 64.
  • 5Nicholls SJ, Uno K, Kataoka Y. Clinical experience with rosuw astatin in the management of hyperlipidemia and the reduction of cardiovascular risk. Expert Rev Cardiovasc Ther, 2011,9: 1383-1390.
  • 6Heart Protection Study Collaborative Group. Effects on l 1- year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high risk individuals:a randomised controlled trial. Lancet, 2011,378: 2013-2020.
  • 7孟兆珂,孙功成,张筱,吴臣,朱琳.1250例社区高血压患者用药情况调查[J].中国药房,2009,20(20):1594-1596. 被引量:3
  • 8周美芳.社区健康宣教在社区高血压病脑卒中危险因素干预中的效果观察[J].中国现代医生,2011,49(11):141-141. 被引量:12
  • 9范利.从高血压治疗最新进展看降压药物的合理选用[J].解放军保健医学杂志,2004,6(2):74-77. 被引量:15

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部